Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.59 |
| ▸ | QRFPR | Q96P65 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 8/20 | 0.40 |
| ▸ | WDR77 | Q9BQA1 | 8/20 | 0.40 |
| ▸ | KDM1A | O60341 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7796723 | 0.93 | HDAC6 (0.59) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL12883422 | 0.84 | HDAC6 (0.60) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL1173788 | 0.81 | HDAC6 (0.55) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL7868061 | 0.80 | HDAC6 (0.57) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL12883087 | 0.77 | HDAC6 (0.60) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL1173979 | 0.76 | HDAC6 (0.66) | HDAC6PRMT5WDR77KDM1A | |
| SCHEMBL7867739 | 0.75 | HDAC6 (0.41) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL7865255 | 0.74 | HDAC6 (0.40) | HDAC6QRFPRKCNH2CYP2D6KCNE1 | |
| SCHEMBL1174737 | 0.74 | HDAC6 (1.00) | HDAC6PRMT5WDR77KDM1A | |
| SCHEMBL1173939 | 0.74 | HDAC6 (0.55) | HDAC6QRFPRKCNH2CYP2D6KCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010151317-A1 | SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-12-29 | — | — | WO | disclosed |